News
Padcev-Keytruda will now join Bristol Myers Squibb’s Opdivo in the list of bladder cancer drugs available on the NHS.
The upcoming Clinical Trials in Rare Diseases conference will cover the most concerning challenges in rare disease research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback